ASXPositive FDA Feedback on NervAlign Nerve Guide Matrix
other announcement
RNV
Health Care Equipment & Services
Renerve
- Short interest
- 0.00%
- as of 6 May 2025
- Reported shorts
- 1.4K
- Shares on issue
- 109.448M
Renerve (RNV) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Change of Director's Interest Notice - P Savage
director_dealing announcement
Change of Director's Interest Notice - M McGuire
director_dealing announcement
Change of Director's Interest Notice - J Chick
director_dealing announcement
Application for quotation of securities - RNV
other announcement
Notification regarding unquoted securities - RNV
other announcement
KalkineReNerve Reports 88% Surge in Annual Revenue and Secures $5M Funding Facility at 2026 AGM
ReNerve (ASX:RNV), a leading developer of nerve repair and regeneration technologies, announced an 88% rise in annual revenue and finalized a $5 million funding facility with Riverfort during its Annual General Meeting presentation in October 2026. The company also shared updates on its commercial activities across the United States and international markets. Key Highlights Annual revenue surged by 88%, with quarterly revenue increasing over 50% compared to the previous quarter. Cash reserves...
Google NewsReNerve (ASX:RNV) Begins Commercial NervAlign Procedures Across Hong Kong and Malaysia - kalkine.com.au
ReNerve (ASX:RNV) Begins Commercial NervAlign Procedures Across Hong Kong and Malaysia kalkine.com.au
ReNerve completes first cases in Hong Kong and Malaysia
other announcement
Change in substantial holding - J Chick
other announcement
Change of Director's Interest Notice - J Chick
director_dealing announcement
ReNerve and RMIT awarded $499k grant
other announcement
Notice of Annual General Meeting/Proxy Form
other announcement
ReNerve (ASX:RNV) Advances Nerve Regeneration Strategy With Expanding Product Portfolio - Kalkine
ReNerve (ASX:RNV) Advances Nerve Regeneration Strategy With Expanding Product Portfolio Kalkine
ReNerve Secures Marketing Approval in the Philippines
other announcement
Change of Director's Interest Notice - J Chick
director_dealing announcement
ReNerve Funding Boost Signals Next Phase of Global Expansion
Highlights ReNerve strengthens funding position for future growth initiatives. Fresh capital supports commercial expansion and product development. International market strategy continues following regulatory progress. ReNerve has secured a new funding facility designed to strengthen its commercial expansion plans, broaden its medical product portfolio, and accelerate international growth initiatives while supporting long-term operational flexibility. T...
ReNerve Secures up to A$5 Million Funding Facility
other announcement
Clarification of Key Terms STC Distribution Agreement
other announcement
ReNerve appoints J4 as second Empliq manufacturing partner
other announcement
ReNerve appoints distribution partner for Malaysian Market
other announcement
ReNerve (ASX:RNV) Expands Asia Footprint with New Distribution Deal - Kalkine
ReNerve (ASX:RNV) Expands Asia Footprint with New Distribution Deal Kalkine
ReNerve (ASX:RNV) just unlocked a market of 88 million people! - Stocks Down Under
ReNerve (ASX:RNV) just unlocked a market of 88 million people! Stocks Down Under
New distribution agreement for broader Hong Kong market
other announcement
Nerve Guide Matrix Enters Stage 3 of Commercial Development
other announcement